Form 144

Selina Management Reaffirms Its Confidence In Its Strategy and Highlights Alignment with Shareholders Through Equity Ownership in the Company

Retrieved on: 
Tuesday, April 9, 2024

These investments underscore management’s confidence in the company's vision and long-term prospects and are in alignment with its current shareholder base.

Key Points: 
  • These investments underscore management’s confidence in the company's vision and long-term prospects and are in alignment with its current shareholder base.
  • Most recently, the executive team converted approximately $500,000 of cash compensation into shares of common stock.
  • However, we do not believe it is based on the fundamentals of the business,” stated Mr. Museri.
  • Selina remains steadfast in its commitment to delivering value to its shareholders, customers, and stakeholders.

Burrell trust adopts Rule 10b5-1 stock disposition plan

Retrieved on: 
Friday, December 8, 2023

The plan was adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and the company's policy regarding stock transactions by insiders.

Key Points: 
  • The plan was adopted in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 and the company's policy regarding stock transactions by insiders.
  • Rule 10b5-1 allows corporate officers and directors to adopt written, pre-arranged stock trading plans when they do not have material, non-public information.
  • The trading plan was adopted for tax planning purposes, and Mr. Burrell intends to retain a majority of the Garmin shares reported as being beneficially owned by him.
  • Any transactions under the plan will be disclosed publicly through Form 144 and Form 4 filings with the Securities and Exchange Commission.

Harpoon Therapeutics Announces Closing of $25 Million Private Placement

Retrieved on: 
Monday, March 27, 2023

The private placement included participation from new and existing investors, including New Leaf, Arix Bioscience, Invus, OrbiMed and K2 HealthVentures.

Key Points: 
  • The private placement included participation from new and existing investors, including New Leaf, Arix Bioscience, Invus, OrbiMed and K2 HealthVentures.
  • SVB Securities provided exclusive financial advisory services to the Company.
  • The proceeds will also be used for working capital and other general corporate purposes.
  • This support will provide us sufficient capital, beyond our anticipated 2023 milestones, into the second half of 2024,” said Julie Eastland, President and CEO of Harpoon.

SEC Updates Electronic Filing Requirements

Retrieved on: 
Friday, June 3, 2022

Furthermore, to benefit investors and the public, electronic filings will be more readily accessible to the public and available on the SEC website in easily searchable formats.

Key Points: 
  • Furthermore, to benefit investors and the public, electronic filings will be more readily accessible to the public and available on the SEC website in easily searchable formats.
  • I am pleased to support these amendments because they will modernize and increase the efficiency of the filing process for filers, investors, and the SEC, said SEC Chair Gary Gensler.
  • These amendments will reduce costs and drive more efficiencies for investors, filers, and the SEC.
  • Electronic filing capabilities have helped address logistical and operational issues raised by the spread of COVID-19.

Logistics Innovation Technologies Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing on or about August 2, 2021

Retrieved on: 
Monday, August 2, 2021

No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

Key Points: 
  • No fractional warrants will be issued upon separation of the units and only whole warrants will trade.
  • Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Companys transfer agent, in order to separate the units into shares of Class A common stock and warrants.
  • A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the SEC) on June 10, 2021.
  • The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

iHerb Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

Retrieved on: 
Thursday, July 22, 2021

PASADENA, Calif., July 22, 2021 /PRNewswire/ -- iHerb Holdings, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its common stock.

Key Points: 
  • PASADENA, Calif., July 22, 2021 /PRNewswire/ -- iHerb Holdings, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its common stock.
  • The number of shares to be offered and the price range for the proposed offering have not yet been determined.
  • The initial public offering is expected to commence after the SEC completes its review process, subject to market and other conditions.
  • This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

iHerb Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

Retrieved on: 
Thursday, July 22, 2021

PASADENA, Calif., July 22, 2021 /PRNewswire/ -- iHerb Holdings, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its common stock.

Key Points: 
  • PASADENA, Calif., July 22, 2021 /PRNewswire/ -- iHerb Holdings, Inc. today announced that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") relating to the proposed initial public offering of its common stock.
  • The number of shares to be offered and the price range for the proposed offering have not yet been determined.
  • The initial public offering is expected to commence after the SEC completes its review process, subject to market and other conditions.
  • This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities.

Amplitude Announces Confidential Submission of Draft Registration Statement for Proposed Direct Listing

Retrieved on: 
Wednesday, July 14, 2021

SAN FRANCISCO, July 14, 2021 (GLOBE NEWSWIRE) -- Amplitude announced today that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the SEC) relating to the proposed direct listing of its Class A common stock.

Key Points: 
  • SAN FRANCISCO, July 14, 2021 (GLOBE NEWSWIRE) -- Amplitude announced today that it has confidentially submitted a draft registration statement on Form S-1 with the Securities and Exchange Commission (the SEC) relating to the proposed direct listing of its Class A common stock.
  • The direct listing is expected to take place after the SEC completes its review process, subject to market and other conditions.
  • This announcement does not constitute an offer to sell or the solicitation of an offer to buy any securities.
  • Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the Securities Act).

Catalyst Partners Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing July 8, 2021

Retrieved on: 
Wednesday, July 7, 2021

Holders of the units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Companys transfer agent, in order to separate the units into Class A ordinary shares and warrants.

Key Points: 
  • Holders of the units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Companys transfer agent, in order to separate the units into Class A ordinary shares and warrants.
  • The units were initially offered by the Company in an underwritten offering.
  • A registration statement relating to the units and the underlying securities was declared effective by the Securities and Exchange Commission (the SEC) on March 17, 2021.
  • The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

DGAP-News: Mister Spex sets final offer price at €25.00 per share

Retrieved on: 
Wednesday, June 30, 2021

These materials do not constitute an offer of securities for sale or a solicitation of an offer to purchase securities (the "Securities") of Mister Spex SE (the "Company") in the United States, Australia, Canada, Japan or any other jurisdiction in which such offer or solicitation is unlawful.

Key Points: 
  • These materials do not constitute an offer of securities for sale or a solicitation of an offer to purchase securities (the "Securities") of Mister Spex SE (the "Company") in the United States, Australia, Canada, Japan or any other jurisdiction in which such offer or solicitation is unlawful.
  • The Securities have not been, and will not be, registered under the Securities Act.
  • This publication constitutes neither an offer to sell nor a solicitation to buy securities.
  • Stabilization transactions may result in a market price that is higher than would otherwise prevail.